NYSE:PHIN • US71880K1016
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PHINIA INC (PHIN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-16 | Freedom Capital Markets | Initiate | Buy |
| 2026-01-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-30 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2025-10-29 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-25 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-19 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-15 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-10 | UBS | Downgrade | Buy -> Neutral |
| 2025-04-10 | B of A Securities | Initiate | Buy |
| 2025-03-24 | CL King | Initiate | Buy |
| 2025-01-30 | Northland Capital Markets | Initiate | Outperform |
| 2025-01-16 | UBS | Maintains | Buy -> Buy |
| 2024-09-25 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-09-04 | UBS | Initiate | Buy |
| 2024-03-12 | Morgan Stanley | Initiate | Overweight |
| 2024-03-11 | Morgan Stanley | Initiate | Overweight |
| 2023-09-05 | Exane BNP Paribas | Initiate | Outperform |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.348B 3.75% | 3.5B 4.54% | 3.403B -2.77% | 3.505B 3.00% | 3.658B 4.37% | 3.708B 1.37% | 3.805B 2.62% | 3.954B 3.92% | 4.051B 2.45% | |
| EBITDA YoY % growth | 530M 20.45% | 504M -4.91% | 478M -5.16% | 486.64M 1.81% | 524.81M 7.84% | 529.37M 0.87% | 534.25M 0.92% | 565.08M 5.77% | 577.32M 2.17% | |
| EBIT YoY % growth | 360M 52.54% | 333M -7.50% | 318M -4.50% | 325.05M 2.22% | 365.11M 12.32% | 389.96M 6.81% | 393.61M 0.94% | 432.48M 9.88% | 440.64M 1.89% | |
| Operating Margin | 10.75% | 9.51% | 9.34% | 9.27% | 9.98% | 10.52% | 10.34% | 10.94% | 10.88% | |
| EPS YoY % growth | N/A | N/A | 3.84 15.84% | 5.05 29.69% | 5.87 17.88% | 6.57 11.98% | 7.78 18.39% | 9.70 24.64% | 9.63 -0.74% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 1.13 19.80% | 1.50 18.22% | 1.63 2.67% | 1.46 24.00% |
| Revenue Q2Q % growth | 869.1M 9.18% | 934.79M 5.03% | 930.49M 2.48% | 889.79M 0.09% |
| EBITDA Q2Q % growth | 115.53M 12.17% | 131.23M -19.49% | 137.54M -34.19% | 128.93M 8.78% |
| EBIT Q2Q % growth | 73.863M 11.91% | 92.101M 5.86% | 98.537M 5.95% | 89.357M 17.04% |
All data in USD
10 analysts have analysed PHIN and the average price target is 84.41 USD. This implies a price increase of 25.57% is expected in the next year compared to the current price of 67.22.
PHINIA INC (PHIN) will report earnings on 2026-04-23.
The consensus EPS estimate for the next earnings of PHINIA INC (PHIN) is 1.13 USD and the consensus revenue estimate is 869.10M USD.
The number of analysts covering PHINIA INC (PHIN) is 10.